This transmission electron microscope image shows SARS-CoV-2-also known as 2019-nCoV, the virus that ... [+] causes COVID-19-isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in the lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like. (Photo by: IMAGE POINT FR - LPN/BSIP/Universal Images Group via Getty Images)
When we get sick we trust our immune system to protect us, but what happens when that system goes awry and ends up killing patients? COVID-19 is shedding new light on how viruses can kick some patients immune system into overdrive to deadly effect in what is known as a cytokine storm syndrome.
In short, our immune system by and large is incredibly effective at working around the clock to keep a myriad of infections and diseases at bay while simultaneously being able to identify between outside invaders and our own cells and effectively prioritise what to attack and what to protect. However, occasionally, either due to genetic factors or rampant viral infections like COVID-19, our immune system can become overzealous and go rogue - attacking and killing everything in sight, including healthy cells in the body. When that happens it is referred to as a cytokine storm and it may be killing around half of severe COVID-19 patients.
Cytokines are inflammatory immunologic proteins that are there to fight off infections and ward off cancers, says Randy Cron, M.D., Ph.D, at theUniversity of Alabama at Birmingham, But when they are out of control, they can make you very ill.
It is important to note that many things have to happen before a potential COVID-19 related cytokine storm is triggered, which is why the majority of COVID-19 patients will never have to deal with the syndrome. According to the Centers for Disease Control (CDC), This first preliminary description of outcomes among patients with COVID-19 in the United States indicates that fatality was highest in persons aged:
Which means that odds are if you contract COVID-19 you will be able to ride it out at home. You can thank the immune system for that because it does not just have one means for defending you against disease, but many many tools in its tool belt to keep you alive.
Dr. Randy Cron, of the University of Alabama, is a leading researcher of cytokine storm syndrome. He explains The data out of China, as well as elsewhere, suggests that about 80% of patients can ride COVID-19 out at home because they are either asymptomatic or feel like their having something like a horrible case of the flu. Continuing, However, about 20% require hospitalization and of those 20% that are being hospitalized, it's entirely unknown what percentage have a cytokine storm so it makes it hard to gauge the mortality of COVID-19 related cytokine storms.
Dr. Cron goes on to explain that the typical mortality rates in adults who develop the syndrome ranges from 50% to 80%. Until further research is done to track COVID-19 related cytokine storm indicating symptoms along with positive cytokine indicating tests we will not yet know just how prevalent cytokine storms are in COVID-19 patients.
Our immune systems are far from simple and have a number of safe guards to keep invaders out. This can be broken down into our innate immune system and our active immune system, which is contributes to our adaptive immune response, as well as our passive immune system, which is "borrowed" from another source and lasts for a short time (for example, antibodies in a mother's breast milk give a baby temporary immunity to diseases the mother has been exposed to).
Put (very) simply, the innate immune system response relies on the use of physical barriers like our skin and mucous membranes, coupled with our first responder defenders like phagocytes, antimicrobial proteins, and attack cells. The innate immune system response is why, for example, we get a stuffy nose and sneeze when we have a cold, or why a scrapped knee gets red, hot and inflamed, as well as sometimes filled with pus. By and large, this first defense is effective and may be why many people who contract COVID-19 are asymptomatic.
However, when the innate immune system isnt enough it calls on our second line of defense; the active immune system. This is typically when the inflammatory response gets kicked into higher gear and you develop a fever, which triggers a number of your bodys chemical alarms that call the active immune system to action and increases the metabolic rates in cells, thus allowing them to heal faster, as well as making it easier for a variety of immune response cells and proteins to do their jobs faster and more effectively. This is also when people start feeling body aches associated with COVID-19 and other viral infections.
The active immune response is both complex and elegant and (again put very simply) not only identifies and fights off viruses like COVID-19, it also remembers these viruses so it can quickly and effectively combat and neutralize them in the future, thus creating immunity. This is why vaccines are one of the more amazing developments of modern medicine. So if all goes well (or relatively well), then our immune system will protect us and we will live to tell the tale, but what happens when things start going awry?
Viruses like COVID-19 have a devious trick up their sleeve when it comes to making us sick; in a sense, they use human cells to shelter and reproduce. When COVID-19 is searching the body for a cellular host to attach to it is fairly exposed and it is easier for our active immune response to target and kill them. COVID-19 wants to do three things when it enters our body; find protection, reproduce and spread. Our cells offer the perfect environment for COVID-19 to do all three. So COVID-19, which targets the respiratory system, attaches and infiltrates our respiratory cells where it can more effectively hide from our immune system early on and reproduce. The infected cell will then spit out more of the COVID-19 virus that will repeat the process. This is where the battle royale of our immune response kicks off with our cellular immune response.
Yet again put very simply, our body has a special cell called the T-Cell, which has a variety of forms that it exists in to combat infection. When T-Cells are activated they release cytokines (yes, that cytokine), which trigger additional T-Cells to be made, which then release even more cytokines. One type of T-cells that are created are called cytotoxic T-cells. Cytotoxic T-cells are the cells that are able to roam the body and mercy kill infected cells who are chemically calling out to be killed and ideally to stop the increased production of viruses like COVID-19.
When your body responds the way it is supposed to, the cytotoxic T-cells will only target infected cells to be killed and move along. Additionally, the immune response also has a chemical indicator that ideally tells overzealous immune response cells to stand down once the threat has been neutralized. It is when we are in the throes of a cytokine storm that those systems start to get overwhelmed and malfunction. In essence, our bodys immune response gets so amped up that it stops differentiating between infected and healthy cells and attacks everything in its path. For obvious reasons, this is very bad for patients because not only is the COVID-19 virus killing the cells in our bodies, now our immune system is too.
Dr. Randy Cron and his colleagues began recognizing instances of cytokine storm syndrome in the early Chinese reports of COVID-19. The way we are seeing cytokine storms manifest in COVID-19 patients are that we are typically seeing a fever and some degree of respiratory distress. He says, However, we are also seeing patients who look like they're in septic shock and become hypotensive as they get sicker. He explains that many COVID-19 patients also have bleeding or clotting abnormalities as well saying, COVID-19 seems to have a really high propensity to lead to clots either in deep veins or in the brain or in the lungs, for example.
Cat Scan. Pneumocystosis In Right Lung. Pneumocystis Carinii Interstitial Pneumonia. (Photo By ... [+] BSIP/UIG Via Getty Images)
However, most notably, COVID-19 patients are most often dying of acute respiratory distress syndrome (ARDS), which indicates that COVID-19 related cytokine storms, like the virus, are focused in the lower lung. This leads to the instances of acute pneumonia and the need for intubation and ventilator use. It also means that patients are dying of cytokine storms faster in instances of COVID-19 than other infections.Most cytokine storm related deaths happen as a result of multi-organ failure, which is why it has such a high mortality rate. Says Dr. Cron, However, with COVID-19 we are seeing people die from pulmonary complications typically before the multi-organ failure can set in. It may just be that patients are getting so sick with their lungs that they're already deathly ill before the rest of the syndrome develops. No one really knows.
Our understanding of cytokine storms is relatively young within the medical field and most of the literature around the syndrome did not take off until the 1990s. There are a lot of people who, both in the lay community and the medical community (particularly if they were trained a longer time ago), that are unfamiliar with cytokine storm syndrome. says Dr. Cron, This syndrome occurs unfortunately every day in ICUs, both in pediatrics and adults across the planet, as a result of a whole variety of conditions that go under-diagnosed and therefore under-treated. However, COVID-19 is changing that.
Luckily, the tests to diagnose cytokine storms are often cheap and readily available in hospitals. Dr. Cron explains that when patients are in throes of a cytokine storm, You will notice an elevation in the serum ferritin, a protein in the blood. Usually the value is less than 200 nanograms per ML and for COVID-19 related cytokine storms, it tends to run between 500 to the low thousands. The test to measure serum ferritin is cheap, readily available in most hospitals, and has a fast turn-around time. If a patients serum ferritin results are elevated, then it is a good early indicator that further testing is needed.
A complete blood count or CBC is a really common standard test. says Dr. Cron, And COVID-19 patients, for whatever reason, seem to be very lymphopenic, meaning their lymphocyte count tends to be less than a thousand per microliter. Continuing that, We don't know if it's more of a cytokine storm feature or just the virus itself, but it certainly suggests that you're not going to do well.
Cytokine storms also can be indicated by liver enzyme abnormalities. The liver gets very unhappy with the cytokine storms and as a result liver enzymes will go up, says Dr Cron, We see also an increase in a protein called D dimers and lactate dehydrogenase (LDH) levels also tend to go up as well. So luckily, despite the relative youth of the field, there are relatively straightforward indicators to diagnose and therefore treat cytokine storms.
There are also a few effective treatments for cytokine storms despite the fact that we still do not know exactly which treatments will ultimately be developed and recommended across the board for COVID-19 related cytokine storms. There's always kind of this push pull between doing no harm and trying therapies that haven't been tried for this disease because it's new to mankind. says Dr. Cron, It's hard to watch people dying in front of you so if you can intervene in some way to help stop that, then that's what doctors are going to do and why some of our colleagues are trying to treat COVID-19 related cytokine storms with just any approach that seems reasonable based on how theyve treated other cytokines storms in the past.
A chemist displays hydroxychloroquine tablets in Kolkata,India on April 10,2020. Amidst concerns ... [+] over domestic shortage, India has lifted the ban on some drug exports including hydroxychloroquine. (Photo by Debajyoti Chakraborty/NurPhoto via Getty Images)
Among other therapies, a few that have recently gotten attention (controversially or otherwise) are hydroxychloroquine and a drug called Actemra. While hydroxychloroquine has been touted by President Trump repeatedly, hospitals have reported mixed results. As Forbes contributor, Anita Bartholomew explains, One of the mostdramatic press reports of apparent successcame from a skilled nursing facility for veterans in Lebanon, Oregon. A doctor treated eight elderly veterans with a combination of hydroxychloroquine and azithromycin (an antibiotic thats been used in tandem with the anti-malarial, and in a French study, showed better results than hydroxychloroquine alone). One died, but the others recovered, including a 103-year old who was seriously declining prior to getting the medication, and survived to celebrate his 104thbirthday on April 1, 2020.
Actemra is a drug that was designed to treat rheumatoid arthritis, but was also approved in 2017 to treat cytokine storms in cancer patients. Actemra was recently successfully used to save a Seattle emergency room doctor who was near death after he contracted COVID-19.
Additionally, There are both broadly immunosuppressive approaches, such as high-dose corticosteroids, and more novel targeted approaches that go after inflammatory cytokine proteins, Dr. Cron said in a Q&A, While we are attempting to develop vaccines for COVID-19 and are trialing novel or re-purposed anti-viral therapies for COVID-19, let us also not forget to treat the patient with all we have to offer to help save lives. We need to address the immediate needs for the significant numbers of patients becoming critically ill in the current pandemic.
While cytokine storms are admittedly terrifying, there is still some hope for COVID-19 patients who develop the syndrome. Now that physicians are more aware of the syndrome and how to identify and treat it we are on track to develop more effective therapies and fail safes that can save more and more patients as the COVID-19 pandemic develops and (eventually) subsides.
Full coverage and live updates on the Coronavirus
See more here:
What Is The Cytokine Storm And Why Is It So Deadly For COVID-19 Patients? - Forbes
- Eosinophil innate immune memory after bacterial skin infection promotes allergic lung inflammation - Science | AAAS - April 5th, 2025
- Researchers Discover mRNA Vaccines Leave Lasting Mark on the Immune System - SciTechDaily - April 5th, 2025
- Scientific Journeys: Uncovering how dioxins affect the immune system - National Institutes of Health (NIH) (.gov) - April 5th, 2025
- Oligodendroglial precursor cells modulate immune response and early demyelination in a murine model of multiple sclerosis - Science | AAAS - April 5th, 2025
- Measles can ravage the immune system and brain, causing long-term damage a virologist explains - The Conversation - April 5th, 2025
- Microscopic Instigators - The University of New Mexico - April 5th, 2025
- Changes in the immune index before and after surgery in urinary malignancy patients with AIDS - Nature - April 5th, 2025
- Non-immune targeting of CXCR3 compromises mitochondrial function and suppresses tumor growth in glioblastoma - Nature - April 5th, 2025
- 8 Supplements That Will Boost Your Immune System - Verywell Health - April 5th, 2025
- Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models - Nature - April 5th, 2025
- Redefining the immune landscape of hepatitis A virus infection - Nature - April 5th, 2025
- What Happens to Your Immune Health When You Take Vitamin C and Zinc Together? - Verywell Health - April 5th, 2025
- Diet Has A Major Impact On The Immune System - WorldHealth.net - April 5th, 2025
- Top 7 ways to boost your immune system - The Indian Express - April 5th, 2025
- Kinetics of pIgR and IgM immune responses in snakehead ( Channa argus ) to inactivated Aeromonas hydrophila via immersion and intraperitoneal... - April 5th, 2025
- What Is Man Flu? - Cleveland Clinic Health Essentials - April 5th, 2025
- Dynamics of T cell subpopulations and plasma cytokines during the first year of antineoplastic therapy in patients with breast cancer: the BEGYN-1... - April 5th, 2025
- Publication in npj Vaccines Reports Cross-reactive and Long-Lasting Immune Responses for self-amplifying mRNA (samRNA) COVID-19 Vaccine Booster... - April 5th, 2025
- 9 Supplements, Tonics, and Oils to Boost Immune Health - W Magazine - April 5th, 2025
- Preoperative pan-immuno-inflammatory values and albumin-to-globulin ratio predict the prognosis of stage IIII colorectal cancer - Nature - April 5th, 2025
- Systemic Lupus Erythematosus (Lupus) - Who gets it? | NIAMS - February 7th, 2025
- Systemic Lupus Erythematosus (Lupus) Basics - National Institute of ... - February 7th, 2025
- Long COVID: women at greater risk compared to men could immune system differences be the cause? - The Conversation - February 7th, 2025
- What is Pemphigus? Symptoms & Causes | NIAMS - February 7th, 2025
- How the immune system influences pancreatic cancer: New interactions provide therapeutic insights - Medical Xpress - February 7th, 2025
- Mitochondrias Secret Power Unleashed in the Battle Against Inflammation - SciTechDaily - February 7th, 2025
- WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis - Nature.com - February 7th, 2025
- The role of the behavioral immune system in the expression of short and long-term orientation in young Chilean men during the COVID-19 pandemic - BMC... - February 7th, 2025
- Harvard nutritionist eats these 5 foods to keep her 'immune system strong' and 'energy high' - CNBC - February 7th, 2025
- Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing - Nature.com - February 7th, 2025
- Personalized Therapeutic Vaccine Steers the Immune System to Fight Kidney Cancer | Newswise - Newswise - February 7th, 2025
- Identification of m6A methyltransferase-related WTAP and ZC3H13 predicts immune infiltrates in glioblastoma - Nature.com - February 7th, 2025
- Serotonin attenuates tumor necrosis factor-induced intestinal inflammation by interacting with human mucosal tissue - Nature.com - February 7th, 2025
- Identification of the immune infiltration and biomarkers in ulcerative colitis based on liquidliquid phase separation-related genes - Nature.com - February 7th, 2025
- FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy - Nature.com - February 7th, 2025
- Young Innovators: U of S researcher uses bat immune systems to find next generation therapies - Saskatoon Star-Phoenix - February 7th, 2025
- World Cancer Day 2025: Chronic stress, immune system, and cancer risk- How are these connected? - The Times of India - February 7th, 2025
- New research unlocks key to long-lasting immune response in cancer and chronic diseases - The Peter Doherty Institute for Infection and Immunity - February 7th, 2025
- Microbial Dynamics and Immune Response to NTHi in COPD - Physician's Weekly - February 7th, 2025
- MHE Week in Review RFK Jr. Spotlight - Managed Healthcare Executive - February 7th, 2025
- Psoriasis Basics: Overview, Symptoms, and Causes - January 27th, 2025
- Vitiligo Symptoms, Treatment & Causes | NIAMS - January 27th, 2025
- The Surprising Connection Between Obesity, Parasites, and Your Immune System - SciTechDaily - January 27th, 2025
- Versatile 69p spice that boosts immune system can go in soups, smoothies and milk - Express - January 27th, 2025
- How the skins secret immune system could lead to needle-free vaccines - Gavi, the Vaccine Alliance - January 27th, 2025
- Fevers link with a key kind of immunity is surprisingly ancient - Science News Magazine - January 27th, 2025
- Immunology - The Scientist - January 27th, 2025
- Opinion: Immune System And Ageing Why We Get More Vulnerable As We Age - ABP Live - January 27th, 2025
- 'Forever chemicals' (PFAS) may weaken immune function in children, leading to more frequent infections - U.S. Right to Know - January 27th, 2025
- Cellular Signals That Wreak Havoc in Sepsis are Revealed - LabRoots - January 27th, 2025
- New Combination Immunotherapy Targets Melanoma and Breast Cancer with Promising Results - Inside Precision Medicine - January 27th, 2025
- New Research in The Journal of Poultry Science: Trained Immunity Offers Novel Poultry Disease Prevention Strategies - PR Newswire - January 27th, 2025
- Scientists uncover how cancer cells hijack T-cells, making it harder for the body to fight back - Medical Xpress - January 27th, 2025
- MiNK Therapeutics Targets Immune Reconstitution to Combat - GlobeNewswire - January 27th, 2025
- Mitochondria may be a promising therapeutic target for inflammatory diseases - Medical Xpress - January 27th, 2025
- Explainer: What is Guillain-Barr Syndrome and how it affects the immune system - Mathrubhumi English - January 27th, 2025
- Yes, Some Vaccines Contain Aluminum. Thats a Good Thing. - The New York Times - January 27th, 2025
- You Are What You Eat? MD Breaks Down The Science Of The Gut Microbiome - mindbodygreen - January 27th, 2025
- Potential gamechanger: Researchers discover basis for immunotherapy-induced myocarditis - Healio - January 27th, 2025
- Ozempic and Wegovy may boost health, from addiction to dementia - BBC.com - January 27th, 2025
- Neutrophil diversity and function in health and disease - Nature.com - December 6th, 2024
- Harnessing the Power of the Immune System for Breast Cancer Treatment - Breast Cancer Research Foundation - December 6th, 2024
- Study Examines Neoantigen Landscapes and Their Role in Immunotherapy Efficacy - Consult QD - December 6th, 2024
- The 5 Best Teas to Support Your Immune System This Cold & Flu Season - EatingWell - December 6th, 2024
- Engineered immune cells may be able to tame inflammation - Medical Xpress - December 6th, 2024
- Hybrid model of tumor growth, angiogenesis and immune response yields strategies to improve antiangiogenic therapy - Nature.com - December 6th, 2024
- Opioids interfere with cancer immunotherapy, but another type of drug could help - Medical Xpress - December 6th, 2024
- RANKL cytokine restores thymus cells in old mice, reducing tumor growth and improving T cell immune response - Fierce Biotech - December 6th, 2024
- Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in... - December 6th, 2024
- Immuno-Oncology Strategic Industry Research Report 2023-2024 & 2030: Approval of Pembrolizumab (Keytruda) and Nivolumab (Opdivo), which Target... - December 6th, 2024
- Study cracks the cold case of immunotherapy resistance - News-Medical.Net - December 6th, 2024
- New immune therapy improves survival and reduces tumor burden in glioblastoma - News-Medical.Net - December 6th, 2024
- Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis - Nature.com - December 6th, 2024
- Immune Cell Breakthrough: Scientists Discover a Hidden Ally in the Fight Against Cancer - SciTechDaily - December 6th, 2024
- Rising temperatures impact the immune system of wild monkeys - Earth.com - December 6th, 2024
- Study declaring Alzheimer's to be a "brain disease" proven to be fabricated - Earth.com - December 6th, 2024
- Warming temperatures impact immune performance of wild monkeys, U-M study shows - University of Michigan News - December 6th, 2024
- New study explores heart risks of cancer immunotherapy - News-Medical.Net - December 6th, 2024
- 'Incredible' way to boost your immune system naturally and ward of colds and flu this winter - The Mirror - December 6th, 2024
- Tis the Season to Boost Your Immune System - Mix93.3 - December 6th, 2024